Download - A new class of diabetes medications
Transcript
![Page 1: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/1.jpg)
A New Class of Diabetes Medications
• Prepared by –Swapnil Chavan
![Page 2: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/2.jpg)
![Page 3: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/3.jpg)
SGLT2 Inhibitors: A New Class of Diabetes Medications
•SGLT2 is a protein in humans that facilitates glucose reabsorption in the kidney. •SGLT2 inhibitors block the reabsorption of glucose in the kidney, increase glucose excretion, and lower blood glucose levels.
![Page 4: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/4.jpg)
![Page 5: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/5.jpg)
• SGLT2 is a high capacity glucose transporter located in the PCT in the kidneys.
• It is responsible for 90% of glucose reabsorption.
• Inhibition of SGLT2 leads to the decrease in blood glucose due to the increase in renal glucose excretion.
![Page 6: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/6.jpg)
• Invokana (canagliflozin) J&J• Jardiance (empagliflozin) B I• Farxiga (dapagliflozin) B.M.S
![Page 7: A new class of diabetes medications](https://reader036.vdocument.in/reader036/viewer/2022080422/58787a7b1a28ab466c8b4ce7/html5/thumbnails/7.jpg)